Читать книгу Practical Cardiovascular Medicine - Elias B. Hanna - Страница 241

1 115. Yasue H, Takizawa A, Nagao M, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988; 78: 1–9. 60% had CAD; CAD not particularly predictor of events.

2 116. Waters DD. Bouchard A. Theroux P. Spontaneous remission is a frequent outcome of variant angina. J Am Coll Cardiol 1983; 2: 195–9. Excluded those who developed MI, CABG. 45% spontaneous remission with no medication.

3 117. Ozaki Y, Takatsu F, Osuqi J, et al. Long-term study of recurrent vasospastic angina using coronary angiograms during ergonovine provocation tests. Am Heart J 1992; 123: 1191–8. This study only took patients without CAD; only 38% had recurrence, often (84%) consistent location and ECG.

4 118. Cipriano PR, Koch FH, Rosenthal SJ, Schroeder JS. Clinical course of patients following the demonstration of coronary artery spasm by angiography. Am Heart J 1981; 101: 127–34. Bad outcome in those with CAD, good if no CAD or receive CABG, but still 3/11 patients without CAD had VT, 1/11 had MI.

5 119. Takagi Y, Yasuda S, Tsunoda R, et al. Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest: multicenter registry study of the Japanese Coronary Spasm Association. Circ Arrhythm Electrophysiol 2011; 4: 295–302. 14% had CAD.

6 120. Aziz A, Hansen HS, Sechtem U, Prescott E,Ong P. Sex-related differences in vasomotor function in patients with angina and unobstructed coronary arteries. J Am Coll Cardiol 2017; 70: 2349–58.

7 121. Ong P, Athanasiadis A, Borgulya G, et al. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation 2014; 129: 1723–1730.

8 122. Ford TJ, Stanley B, Sidik N, et al. 1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA). JACC Cardiovasc Interv. 2020; 13(1):33–45.

9 123. Bott-Silverman C, Heupler FA. Natural history of pure coronary artery spasm in patients treated medically. J Am Coll Cardiol 1983; 2: 200–5.

10 124. Yasue H, Mizuno Y, Harada E, et al. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after with- drawal of calcium-channel blockers. J Am Coll Cardiol. 2008; 51: 1742–8.

11 125. Myerburg RJ, Kessler KM, Mallon SM, et al. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. N Engl J Med 1992; 326: 1451–5.

12 126. Meisel SR, Mazur A, Chetboun I, et al. Usefulness of implantable cardioverter-defibrillators in refractory variant angina pectoris complicated by ventricular fibrillation in patients with angiographically normal coronary arteries. Am J Cardiol 2002; 89: 1114–16.